Filing Details
- Accession Number:
- 0001209191-21-019247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-09 18:56:09
- Reporting Period:
- 2021-03-08
- Accepted Time:
- 2021-03-09 18:56:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679363 | Morphic Holding Inc. | MORF | Pharmaceutical Preparations (2834) | 473878772 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1773184 | Marc Schegerin | C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451 | Cfo And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-08 | 3,000 | $63.50 | 6,379 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 1,379 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 26, 2021.
Billionaire Hedge Funds
